A phase I study of hydralazine to demethylate and reactivate the expression of tumor suppressor genes

A phase I study of hydralazine to demethylate and reactivate the expression of tumor suppressor genes is a paper indexed in PICO Portal from OpenAlex.

How many citations does A phase I study of hydralazine to demethylate and reactivate the expression of tumor suppressor genes have?

A phase I study of hydralazine to demethylate and reactivate the expression of tumor suppressor genes has 150 citations in the OpenAlex counts PICO Portal stores.

When was A phase I study of hydralazine to demethylate and reactivate the expression of tumor suppressor genes published?

A phase I study of hydralazine to demethylate and reactivate the expression of tumor suppressor genes has 2005 year in the PICO Portal index.

What is the open-access status of A phase I study of hydralazine to demethylate and reactivate the expression of tumor suppressor genes?

A phase I study of hydralazine to demethylate and reactivate the expression of tumor suppressor genes has gold oa status in the PICO Portal index.

What is the DOI of A phase I study of hydralazine to demethylate and reactivate the expression of tumor suppressor genes?

The DOI for A phase I study of hydralazine to demethylate and reactivate the expression of tumor suppressor genes is on the source record.

What is the PMID of A phase I study of hydralazine to demethylate and reactivate the expression of tumor suppressor genes?

The PMID for A phase I study of hydralazine to demethylate and reactivate the expression of tumor suppressor genes is on the source record.

What is the OpenAlex record for A phase I study of hydralazine to demethylate and reactivate the expression of tumor suppressor genes?

The OpenAlex for A phase I study of hydralazine to demethylate and reactivate the expression of tumor suppressor genes is on the source record.